BIDJ.J

BIDJ.J has a liquidity position that is characterized by a current ratio of 1.31, indicating that it has sufficient current assets to cover its current liabilities, though not by a large margin. The company's liquidity is assessed as medium, with a key flag noting that net cash is negative after subtracting total debt, suggesting that the company's cash and equivalents are less than its long-term debt. In terms of profitability, BIDJ.J reports a return on equity of 17.28% and a return on assets of 6.76%, which are metrics that reflect the company's efficiency in generating profits from its equity and total assets, respectively. The company's debt-to-equity ratio is 0.55, indicating a moderate level of leverage that is below the industry median for its sector. The company's revenue is concentrated in the Food & Drug Retailing segment, with no disclosed geographic diversification provided in the available data. This concentration may expose the company to specific market risks associated with its primary business activities. BIDJ.J's growth trajectory is not explicitly detailed in the available data, but the company's operating income and net income suggest a stable performance. Analysts have provided a mean price target of 492.62 ZAR, with a median of 483.00 ZAR, indicating a generally positive outlook. The risk assessment for BIDJ.J indicates a low potential for dilution, with a key flag highlighting the negative net cash position after subtracting total debt. This suggests that the company may need to raise additional capital in the future, which could lead to dilution of existing shareholders' equity. Recent events and filings have not been detailed in the provided data, so no specific recent developments can be cited for BIDJ.J.